Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2021 - Issue 4

Evaluation of Membranous Nephropathy Diagnostic and Management Approach Download PDF


, , , , , , , , ,
Abstract

Membranous nephropathy is one of the most common causes of nondiabetic adults' nephrotic syndrome. It accounts for up to 30% of nephrotic syndrome cases in Caucasian adults. It can manifest as a primary or secondary disease, but primary is considered more common. The disease has a waxing and waning clinical course and indolent progress, and immunosuppressive treatment is deemed the mainstay therapy for promoting remission. Although there has been advancement in understanding the pathogenesis of this disease, it still requires further research. We aimed to review the literature to promote the understanding of membranous nephropathy. We reviewed the literature for membranous nephropathy; pathogenesis, etiology, clinical presentation, diagnosis, and treatment. Articles were chosen from the PubMed database, and selected studies were subjected to a thorough review. Membranous nephropathy is one of the most common causes of nephrotic syndrome in nondiabetic adults. The clinical course of this disease is waxing and waning and has indolent progression. Despite the improvement in diagnostic approaches and treatment options, it remains an active field for diagnostic and pharmacological research.

Cite this article
Vancouver
Bokheder MA, Asiri BBSA, Alsarah AKA, Alshahrani NA, Al Tarish SM, Harakati AM, et al. Evaluation of Membranous Nephropathy Diagnostic and Management Approach. Pharmacophore. 2021;12(4):73-8. https://doi.org/10.51847/qixenY6Ym6
APA
Bokheder, M. A., Asiri, B. B. S. A., Alsarah, A. K. A., Alshahrani, N. A., Al Tarish, S. M., Harakati, A. M., Almuntashiri, I. A. A., Alamir, F. A., Alshmri, S. M., & Alkhaldi, G. N. (2021). Evaluation of Membranous Nephropathy Diagnostic and Management Approach. Pharmacophore, 12(4), 73-78. https://doi.org/10.51847/qixenY6Ym6

QR code:

Short Link:
Quick Access

Associations

Pharmacophore
ISSN: 2229-5402

Copyright © 2024 Pharmacophore. Authors retain copyright of their article if they are accepted for publication.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.